Amalgamated Bank Aspira Women'S Health Inc. Transaction History

Amalgamated Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $4,735 - $12,903	-11,838 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.88 - $1.81 $877 - $1,804	-997 Reduced 7.77%	11,838 $12,000
Q4 2021 Feb 15, 2022	SELL	$1.63 - $3.43 $733 - $1,543	-450 Reduced 3.39%	12,835 $23,000
Q3 2021 Oct 29, 2021	SELL	$3.19 - $5.48 $1,416 - $2,433	-444 Reduced 3.23%	13,285 $43,000
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $10,152 - $14,528	2,124 Added 18.3%	13,729 $77,000
Q1 2021 May 13, 2021	SELL	$5.9 - $9.13 $1,805 - $2,793	-306 Reduced 2.57%	11,605 $78,000
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $276 - $617	92 Added 0.78%	11,911 $79,000
Q3 2020 Oct 30, 2020	BUY	$2.54 - $4.56 $30,020 - $53,894	11,819 New	11,819 $36,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.